The Australian Parkinson's Mission, an innovative 5 year research program, combines clinical trials and biomarker technologies with breakthrough genomics for people living with Parkinson's.
We hope to identify and validate a precision medicine framework for treating and preventing Parkinson's disease.
Coronavirus information for patients
The APM clinical trials were due to commence recruitment shortly, however, unfortunately due to COIVID-19 these will now be delayed. We will continue to keep you updated on recruitment timeframes for APM clinical trials via this website. Please read APMs response to COVID-19 protocols (30 March 2020)